title: Periodontal Disease, Dental Implants, Extractions and Medications Related to Osteonecrosis of the Jaws.
abstract: Patients taking bisphosphonates and other anti-resorptive drugs are likely to attend general dental practice. The term 'bisphosphonate'is often immediately associated with osteonecrosis of the jaws (ONJ). Risk assessment and subsequent management of these patients should be carried out taking into account all the risk factors associated with ONJ. The introduction of newer drugs, also shown to be associated with ONJ, demands increased awareness of general dental practitioners about these medications. CPD/CLINICAL RELEVANCE: This paper provides an update on medication-related ONJ and considers the effects of anti-resorptive drugs on the management of patients needing exodontia, treatment for periodontal disease and dental implant placement.
authors.forename: Neha P
authors.initials: NP
authors.lastname: Shah
authors.forename: Helen
authors.initials: H
authors.lastname: Katsarelis
authors.forename: Michael
authors.initials: M
authors.lastname: Pazianas
authors.forename: Daljit K
authors.initials: DK
authors.lastname: Dhariwal
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000517:prevention & control*; D050071:Bone Density Conservation Agents / Q000009:adverse effects; D015921:Dental Implants; D004164:Diphosphonates / Q000009:adverse effects; D006801:Humans; D010510:Periodontal Diseases / Q000628:therapy*; D018570:Risk Assessment; D014081:Tooth Extraction
chemical_list: D020533:Angiogenesis Inhibitors; D050071:Bone Density Conservation Agents; D015921:Dental Implants; D004164:Diphosphonates